Identification of the Oka strain of the live attenuated varicella vaccine from other clinical isolates by molecular epidemiologic analysis

Journal of Infectious Diseases

Volumn 178, Issue 1, 1998, Pages 35-38

  Mori, Chisato ^b   Takahara, Rie ^b   Toriyama, Tetsuro ^b   Nagai, Takao ^b   Takahashi, Michiaki ^b   Yamanishi, Koichi ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; SUDUVAX; UNCLASSIFIED DRUG; VARICELLA ZOSTER VACCINE;

ARTICLE; DNA DETERMINATION; GENE MAPPING; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; VACCINATION; VARICELLA ZOSTER VIRUS; VIRUS ISOLATION; VIRUS STRAIN;

EID: 0031870066     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515598     Document Type: Article

References (13)

1. Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T, Isomura S. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 1974;2:1288-90.
2. Hayakawa Y, Torigoe S, Shiraki K, Yamanishi K, Takahashi M. Biologic and biophysical markers of a live varicella vaccine strain (Oka): identification of clinical isolates from vaccine recipients. J Infect Dis 1984;149:956-63.
3. Hayakawa Y, Yamamoto T, Yamanishi K, Takahashi M. Analysis of varicella-zoster virus DNAs of clinical isolates by endonuclease Hpal. J Gen Virol 1986;67:1817-29.
4. Shiraki K, Horiuchi K, Asano Y, Yamanishi K, Takahashi M. Differentiation of Oka varicella vaccine strain from wild varicella zoster virus strains isolated from vaccinees and household contact. J Med Virol 1991:33:128-32.
5. Takada M, Suzutani T, Yoshida I, Matoba M, Azuma M. Identification of varicella-zoster virus strain by PCR analysis of three repeat elements and a PstI site-less region. J Clin Microbiol 1995;33:658-60.
6. Hawrami K, Harper D, Breuer J. Typing of varicella zoster virus by amplification of DNA polymorphisms. J Virol Methods 1996;57:169-74.
7. Hondo R, Yogo Y, Yoshida M, Fujima A, Itoh S. Restriction of varicella-zoster virus strains carrying a PstI-site-less mutation in Japan and DNA change responsible for the mutation. Jpn J Exp Med 1989;59:233-7.
8. LaRussa P, Lungu O, Hardy I, Gershon A, Steinberg SP, Silverstein S. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J Virol 1992;66:1016-20.
9. Straus SE, Hay J, Smith H, Owen J. Genome differences among varicella-zoster virus isolates. J Gen Virol 1983;64:1031-41.
10. Martin JH, Dohner DE, Wellioghoff WJ, Gelb LD. Restriction endonuclease analysis of varicella-zoster virus and wild-type DNAs. J Med Virol 1982;9:69-76.
11. Davison AJ, Edson CM, Ellis RW, et al. New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products. J Virol 1986;57:1195-7.
12. Davison AJ, Scott J. The complete DNA sequence of varicella-zoster virus. J Gen Virol 1986;67:1759-816.
13. Kinchington PR, Ling P, Pensiero M, Moss B, Ruyechan WT, Hay J. The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka). J Virol 1990;64:4540-8.